Table 2.
Label | Variability Independent of the Mean (units) |
Difference Between Maximum and Minimum Blood Pressure (mm Hg) |
Average Real Variability (mm Hg) |
---|---|---|---|
Variance explained | |||
Total | 0.138 | 0.306 | 0.403 |
Pedigree | 0.117 | 0.150 | 0.226 |
Fixed effects | 0.021 | 0.157 | 0.178 |
Parameter estimates (SE) | |||
Female sex | −0.245 (0.102)* | — | — |
Age, +10 y | 0.205 (0.038)§ | 0.658 (0.105)§ | 0.138 (0.025)§ |
Body mass index, +5 kg/m2 | −0.208 (0.064)† | −0.630 (0.178)‡ | −0.116 (0.043)† |
Systolic blood pressure, +10 mm Hg | −0.077 (0.039)* | 1.787 (0.105)§ | 0.347 (0.025)§ |
Heart rate, +5 bpm | — | — | 0.054 (0.019)† |
Total/high-density lipoprotein cholesterol, +1 unit | — | −0.164 (0.086)* | −0.104 (0.021)§ |
Plasma glucose, +1 mmol/L | — | — | 0.066 (0.026)* |
Serum creatinine, +10 μmol/L | — | −0.246 (0.083)† | — |
Peripheral arterial disease | 1.254 (0.492)* | 3.538 (1.338)† | — |
Treated with β-blockers | 0.494 (0.209)* | 1.425 (0.567)* | — |
Systolic blood pressure was based on 10 blood pressure readings, that is, 5 consecutive blood pressure readings at each of 2 home visits at an interval of 2 to 4 weeks. The following variables were not related to any index of variability: energy expenditure in physical activity, triglycerides, history of cardiovascular disease, smoking and alcohol intake, diabetes mellitus, and classes of antihypertensive drugs other than β-blockers.
Significance of the parameter estimates:
P≤0.05;
P≤0.01;
P≤0.001; and
P≤0.0001.